Ori Biotech
London
About Ori Biotech
Ori Biotech is a developer of a manufacturing platform used to help patients get access to lifesaving treatments. Ori has developed a proprietary, flexible manufacturing platform that closes, automates, and standardizes manufacturing allowing therapeutics developers to further develop and bring their products from pre-clinical process development to commercial-scale manufacturing. The company aims to speed up the innovation of cell and gene therapies through the manufacturing platform it is bringing to market.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $139.1M
- Funding stage: Early Stage Venture
- Last round: Series B (Jan 2022)
- Website: oribiotech.com
Industries & Categories
Biotechnology, Industrial Automation, Manufacturing, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/ori-biotech-59756 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.